{"id":207529,"name":"BEYOND TYPE 1","slug":"beyond-type-1","state":"CA","country":"United States of America","description":"","totalSpending":0,"filings":9,"yearlySpending":[{"year":2020,"income":0},{"year":2021,"income":0},{"year":2022,"income":0}],"issues":[{"code":"HCR","display":"Health Issues"}],"firms":["BEYOND TYPE 1"],"lobbyists":["CHRISTEL APRIGLIANO"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Centers For Medicare and Medicaid Services (CMS)"],"sampleDescriptions":["Insulin, diabetes, CGM, DSMT","S.2199/H.R.4906 Insulin Price Reduction Act support, Special Diabetes Program (extension to 2024)","Insulin affordability\nPrescription drug affordability\nImproving diabetes device access\nSupport for H.R.379 Improving Social Determinants of Health Act of 2021","Insulin affordability\nPrescription drug affordability\nImproving diabetes device access\nSupport for H.R.379 Improving Social Determinants of Health Act of 2021\nSupport for S.1424 Chronic Disease Manage","Insulin affordability\nPrescription drug affordability\nImproving diabetes device access\nSupport for H.R.379 Improving Social Determinants of Health Act of 2021\nSupport for S.1424 Chronic Disease Manage"]}